Literature DB >> 8024089

Vaccines against arthropods.

B H Kay1, D H Kemp.   

Abstract

The possibility of vaccinating hosts against blood-feeding arthropods using antigens derived from salivary gland, gut, and other tissues is reviewed. These vaccines directed against vector arthropods also have the potential to effect the arthropods capacity to transmit pathogens, and this is distinct from transmission-blocking vaccines that use antigens derived from pathogens. Antigen extracts have been used in attempts to vaccinate against fleas, lice, keds, flies, mosquitoes, and a number of tick species. A vaccine against the cattle tick, Boophilus microplus (Canestrini), using a recombinant antigen, has been tested under field conditions. Ticks feeding on vaccinated hosts are damaged by an immune response directed against their gut cells. Some die on the host, others engorge but their fecundity is reduced. The Commonwealth Scientific Industrial Research Organization-Biotechnology Australia tick vaccine against B. microplus is cited as a model for the development of other vaccines. It is suggested that the weaker effects of vaccines against insects as compared with ticks are related to the different structure and physiologies of the gut rather than being related to time spent on the vertebrate host. These differences in the effects of vaccines on insects may favor vaccines which block the passage of pathogens into vector insects. Vaccines against mosquitoes have been shown to reduce susceptibility of mosquitoes to arboviruses. The potential of the different vaccines is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024089     DOI: 10.4269/ajtmh.1994.50.87

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Molecular characterization of a Haemaphysalis longicornis tick salivary gland-associated 29-kilodalton protein and its effect as a vaccine against tick infestation in rabbits.

Authors:  A Mulenga; C Sugimoto; Y Sako; K Ohashi; A Musoke; M Shubash; M Onuma
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Morphological alterations of Metarhizium anisopliae during penetration of Boophilus microplus ticks.

Authors:  Walquíria Arruda; Irina Lübeck; Augusto Schrank; Marilene Henning Vainstein
Journal:  Exp Appl Acarol       Date:  2005       Impact factor: 2.132

3.  Induction of mosquitocidal activity in mice immunized with Anopheles gambiae midgut cDNA.

Authors:  B D Foy; T Magalhaes; W E Injera; I Sutherland; M Devenport; A Thanawastien; D Ripley; L Cárdenas-Freytag; J C Beier
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

4.  Aedes aegypti SNAP and a calcium transporter ATPase influence dengue virus dissemination.

Authors:  Alejandro Marin-Lopez; Junjun Jiang; Yuchen Wang; Yongguo Cao; Tyler MacNeil; Andrew K Hastings; Erol Fikrig
Journal:  PLoS Negl Trop Dis       Date:  2021-06-11

5.  Francisella-arthropod vector interaction and its role in patho-adaptation to infect mammals.

Authors:  Christine Akimana; Yousef Abu Kwaik
Journal:  Front Microbiol       Date:  2011-02-18       Impact factor: 5.640

Review 6.  Tick-borne diseases of bovines in Pakistan: major scope for future research and improved control.

Authors:  Abdul Jabbar; Tariq Abbas; Zia-ud-Din Sandhu; Hafiz A Saddiqi; Muhammad F Qamar; Robin B Gasser
Journal:  Parasit Vectors       Date:  2015-05-22       Impact factor: 3.876

7.  Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein.

Authors:  Berlin Londono-Renteria; Andrea Troupin; Michael J Conway; Diana Vesely; Michael Ledizet; Christopher M Roundy; Erin Cloherty; Samuel Jameson; Dana Vanlandingham; Stephen Higgs; Erol Fikrig; Tonya M Colpitts
Journal:  PLoS Pathog       Date:  2015-10-22       Impact factor: 6.823

Review 8.  Arbovirosis and potential transmission blocking vaccines.

Authors:  Berlin Londono-Renteria; Andrea Troupin; Tonya M Colpitts
Journal:  Parasit Vectors       Date:  2016-09-23       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.